Document:

QuickLinks
 -- Click here to rapidly navigate through this document

  

 
 

  Exhibit 10.1    
    

August 6,
2010 

[NAME
OF EMPLOYEE]

[ADDRESS] 

Dear
[FIRST NAME]: 

        This
letter agreement (this "Agreement") sets forth the arrangements between Helicos BioSciences Corporation (the
"Company") and you in connection with your continued employment with the Company as it considers alternatives to its existing long-term
strategic focus, including a repositioning of the Company in the genetic analysis markets. We would like to retain your focused and committed efforts during this period of uncertainty in exchange for
the benefits and incentives detailed in this Agreement in addition to other compensation you may earn from your service to the Company. 

        1.     Restricted Stock Award

        (a)    Award.    Upon the fifth (5th) business day after the Company's shareholders approve an increase
in the number of shares reserved for issuance under the Company's 2007 Stock and Option Incentive Plan or a successor plan (the "2007 Plan"), the
Company agrees to grant you a restricted stock award ("Award") of the Company's common stock, par value $0.001 per share
("Common Stock"), under the 2007 Plan in the amount of [NUMBER] shares. The Award will vest according to the following vesting
schedule (the "Vesting Schedule"): 

 

 

					
	 January 1, 2011
	 	 	12.5%	 
	 July 1, 2011
	 	 	12.5%	 
	 January 1, 2012
	 	 	12.5%	 
	 July 1, 2012
	 	 	12.5%	 
	 January 1, 2013
	 	 	12.5%	 
	 July 1, 2013
	 	 	12.5%	 
	 January 1, 2014
	 	 	12.5%	 
	 July 1, 2014
	 	 	12.5%	 
	 	 	 	 
	 
	 	 	100%	 

 

         Your
Award will be documented by and shall be subject to the terms of the 2007 Plan and the Company's standard Restricted Stock Award Agreement that will be entered into between you and
the Company. 

        (b)    Contingency for Available Shares.    If, upon any increase in the number of shares reserved under the 2007 Plan
(including by way of Company shareholder approval or the evergreen provisions contained in the 2007 Plan), there are insufficient shares available under the 2007 Plan to satisfy your Award and all
similar restricted stock awards to other members of the Company's management team pursuant to letter agreements similar to this Agreement, you and such other members of the Company's management team
will receive a pro rata portion of available shares in respect of such restricted stock awards until sufficient shares are reserved thereafter under the 2007 Plan, if ever. Please note that the
Company cannot guarantee that shareholder approval of an increase in the number of shares reserved under the 2007 Plan will be received. 

 

        (c)    Change in Control Protection.    If, prior to the issuance of your entire Award or Anti-Dilution
Award(s) (as defined below), there is a Terminating Event (as defined below) within twelve (12) months after the consummation of a Change in Control of the Company (as defined below), the
Company or its successor in such Change in Control (as the case may be) shall make (x) a lump sum cash payment to you in respect of such unissued portion of your Award and
Anti-Dilution Award(s), as applicable, in an amount equal to the fair market value of such unissued portion of your Award and Anti-Dilution Award(s), as applicable, determined
immediately prior to the consummation of such Change in Control or (y) appropriate provision for the substitution of the unissued portion of your Award and Anti-Dilution Award(s),
as applicable, with new awards of securities of the Company, its successor in such Change in Control, or the parent entity of the Company or such successor, with appropriate adjustment as to the
number and kind of securities as the Committee (as defined below) shall specify. For clarity, any portion of your Award and Anti-Dilution Award(s) actually issued in advance of any Change
in Control shall be governed by the terms of the Restricted Stock Award Agreement between you and the Company in respect thereof, the 2007 Plan, the Change in Control Agreement between you and the
Company and any other applicable agreement between you and the Company and not by the preceding sentence. 

        (i)    For
purposes of this Agreement, "Terminating Event" shall have the meaning ascribed thereto in the Change in Control
Agreement between you and the Company. 

        (ii)   For
purposes of this Agreement, a "Change in Control" shall mean a strategic transaction involving an acquisition of all
of the Company's then outstanding Common Stock by a third party or any consolidation or merger of the Company where the stockholders of the Company, immediately prior to the consolidation or merger,
would not, immediately after the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or
indirectly, shares representing in the aggregate more than 50 percent of the voting shares of the Company issuing cash or securities in the consolidation or merger (or of its ultimate parent
corporation, if any), provided, however that a liquidation, winding up or dissolution of the Company in
the absence of a strategic transaction shall not be deemed to be a "Change in Control" of the Company for purposes of this Agreement. 

        (d)    Anti-Dilution Protection.    

        (i)    Your
Award shall be subject to anti-dilution protection which will be triggered in the event that the Company effects an equity or equity-linked financing,
whether strategic or otherwise, beginning with and including the Company's next equity or equity-linked financing consummated following June 21, 2010 and continuing during the
twenty-four (24) month period after such next financing until the Company has raised an aggregate of twenty-five million dollars ($25,000,000) in net proceeds in one or
more such financings (each such financing, a "Company Financing"). 

        (ii)   Pursuant
to the anti-dilution provision described in the previous paragraph, within five (5) business days after the occurrence of any Company
Financing, the Company will grant you an additional restricted stock award of Common Stock in an amount determined by (i) multiplying the Corporation's reserved and outstanding Common Stock
equivalents after such Company Financing (which for clarity shall include all outstanding shares of Common Stock, securities exercisable for or convertible into Common Stock, and shares of Common
Stock reserved but unissued under the Plan and any other then effective incentive equity compensation plan of the Corporation) by your "fully diluted equity percentage" of [INDIVIDUAL
PERCENTAGE] less (ii) shares of Common Stock in the amount of [INSERT CURRENT RESTRICTED STOCK AMOUNT]  less (iii) shares of Common Stock issued
under the Award described in Section 1 of this Agreement  less (iv) shares of Common Stock previously issued to you as an anti-dilution adjustment in respect of
 

2

 

any
prior Company Financing (any such additional issuances calculated by subtracting (ii), (iii) and (iv) from (i), the "Anti-Dilution
Awards"). 

        (iii)  Each
Anti-Dilution Award(s) will vest according to the Vesting Schedule. In addition, your right to receive any Anti-Dilution Award shall be
contingent upon there being sufficient shares available under 2007 Plan or, if there are not, receipt of shareholder approval of the requisite subsequent increase in shares reserved under the Plan.
If, after completion of a Company Financing and the satisfaction of any then pending obligation of the Company to issue new awards under the 2007 Plan (other than anti-dilution protection
obligations), there are insufficient shares available under 2007 Plan to satisfy your Anti-Dilution Awards and any similar anti-dilution protection obligation to other Company
employees, you and such other employees will receive a pro rata portion of available shares in respect of the Anti-Dilution Award to which you are entitled until the Company receives
shareholder approval of a requisite subsequent increase in shares reserved under the Plan, if ever. Please note that the Company cannot guarantee that such shareholder approval will be received. All
Anti-Dilution Awards will be documented by and shall be subject to the terms of the 2007 Plan and the Company's standard Restricted Stock Award Agreement that will be entered into between
you and the Company. 

        2.     Cash/Unrestricted Stock Award. 

        (a)    Award and Timing of Payment.    The Company shall grant you a retention award having a value of
$[AMOUNT] (the "Cash/Stock Payment") upon the following schedule and terms. 

        (i)    First Installment:    If the Company has at least fifteen million dollars ($15,000,000) in cash and cash
equivalents (including liquid investment securities) on its balance sheet (the "Requisite Cash Balance") after the closing of the first equity or
equity-linked financing subsequent to the date hereof and such financing yields a minimum of ten million dollars ($10,000,000) in net proceeds, the Company will deliver to you fifty percent (50%) of
your Cash/Stock Payment (the "First Installment"). The Company will deliver the First Installment on or before the thirty-sixth (36th)
business day following such first financing. In the event that the Company does not have the Requisite Cash Balance as of the closing of such first financing but thereafter the Company achieves the
Requisite Cash Balance, Company will deliver to you the First Installment within five (5) business days after the Company achieves the Requisite Cash Balance, if ever. 

        (ii)    Second Installment:    Provided that the First Installment described in the preceding paragraph has been
achieved, the Company will deliver to you fifty percent (50%) of your Cash/Stock Payment within five (5) business days after the Company has received an aggregate of five-hundred
thousand dollars ($500,000) in proceeds from the sale of diagnostic services. 

        (b)    Form of Award.    The compensation committee (the "Committee") of the Company's board of directors will
determine whether to make your Cash/Stock Payment in a lump sum cash payment or in the form of shares of unrestricted Common Stock within thirty-five (35) trading days after the
closing of the financing referred to in Section 2(a)(i). If the Committee determines to pay the Cash/Stock Payment in shares of unrestricted Common Stock:  

	•
	The number of shares of unrestricted Common Stock to which you are entitled in respect of both the First Installment and
the Second Installment shall be determined by dividing the amount set forth in Section 2(a) by the 30-day average closing price of the shares of Common Stock, as reported by Nasdaq
Stock Market LLC (or the primary market on which the Common Stock then trades), following the closing of the financing referred to in Section 2(a)(i).   

	•
	The issuance of your shares of unrestricted Common Stock is subject to there being sufficient shares available under 2007
Plan to satisfy your First Installment or the Second Installment, as the case may be, and all similar unrestricted Common Stock awards to other members of the Company's management team pursuant to
letter agreements similar to this Agreement. If there 

3

 

are
insufficient shares available under 2007 Plan to satisfy all such unrestricted Common Stock awards, you and such other members of the Company's management team will receive a pro rata portion of
available shares in respect of such unrestricted Common Stock awards until sufficient shares are reserved thereafter under the 2007 Plan, if ever. Please note that the Company cannot guarantee that
shareholder approval of an increase in the number of shares reserved under the 2007 Plan will be received. 

        3.     Impact of this Agreement on Employment and Other Agreements.

        Notwithstanding
anything to contrary herein, your employment shall be deemed an employment at will and your employment may be terminated at will by you or the Company at anytime for any
or no reason except that you agree to give the Company written notice at least thirty (30) calendar days in advance of you terminating your employment, provided that the Company may waive any
obligation to continue your employment after such written notice is received. The benefits to which you are entitled hereunder are in addition to the benefits to which you may be entitled under any
other agreements with the Company except that (i) payments hereunder may be limited by, and deemed to be "Severance Payments" under, Section 5 of your Change in Control Agreement with
the Company and (ii) the Award and Anti-Dilution Award(s), if and to the extent actually issued, shall be governed by the terms of the Restricted Stock Award Agreement between you
and the Company in respect thereof, the 2007 Plan, the Change in Control Agreement between you and the Company and any other applicable agreement between you and the Company in respect of equity
awards generally. Except as provided in Section 1(c), the benefits to which you are entitled hereunder will terminate in connection with the termination of your employment. 

        4.     Section 409A.

        Notwithstanding
anything in this Agreement to the contrary, in the event that any benefits payable or otherwise provided under this Agreement would be deemed to constitute
non-qualified deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended ("Section 409A"),
you and the Company shall adjust the terms of such payment or benefit in a commercially reasonable manner to comply in good faith with the requirements of Section 409A and to avoid the
imposition of any excise tax or other penalty with respect to such payment or benefit under Section 409A, including agreeing to delay the receipt of any payments to a six-month wait
after your separation from service. 

        5.     Miscellaneous.

        (a)    Entire Agreement.    This Agreement sets forth the entire agreement between the parties hereto with respect to
its subject matter, and supersedes and replaces any and all previous oral or written communications, representation, promises or agreements between the parties relating to this subject. 

        (b)    Amendment.    This Agreement may not be changed or otherwise modified except by an instrument in writing signed
by you and an authorized representative of the Company. 

        (c)    Governing Law.    This Agreement shall be governed by and construed in accordance with the laws of
Massachusetts. 

        (d)    No Waiver.    The failure of the Company or you to insist upon strict adherence to any term of this Agreement
on any occasion shall not be considered a waiver of such party's rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. 

        (e)    Severability.    In the event that anyone or more of the provisions of this Agreement shall be or become
invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement outstanding shall not be affected thereby. 

4

 

        (f)    Arbitration.    Any claim or controversy arising from your employment with the Company, the termination of your
employment, this Agreement, or any other related matter will be resolved by final and binding arbitration under the Employment Dispute Resolution Rules of the American Arbitration Association. This
arbitration remedy will be exclusive. To invoke the arbitration remedy, the complaining party must give notice in writing to the other party and to the American Arbitration Association of his or its
intention to arbitrate within the statue of limitations applicable to the controversy and must first submit the matter to a non-binding mediation before a mediator agreed upon by the
parties. The arbitrator will have the authority to grant the same remedies that could be awarded by a court of competent jurisdiction. The arbitrator will issue findings of fact and conclusions of law
supporting the award. The losing party in any such dispute will pay all of the winning party's costs, including any arbitrator or administrative fees and reasonable attorneys' fees. Any arbitration
will be held in Massachusetts. 

        (g)    Notice.    For the purpose of this Agreement, notices and all other communications provided for in this
Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the
respective addresses set forth on the execution page of the letter agreement, provided that all notices to the Company shall be directed to the
attention of the General Counsel of the Company, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address
shall be effective only upon receipt. 

        (h)    Withholding Taxes.    The Company may withhold from any amounts payable under this Agreement such U.S. federal,
state and local taxes as may be required to be withheld pursuant to any applicable law or regulation. 

        (i)    Counterparts.    This Agreement may be signed in counterparts, each of which shall be an original, with the
same effect as if the signatures thereto and hereto were upon the same instrument. 

 

 

					
	 	 	Sincerely,
	

 	
 	
By:	
 	

  Company Representative

 

 

 

					
	Accepted and Agreed:	 	 
	
 By:	
 	

  [NAME OF EMPLOYEE]

	
 	

 

 

 5

QuickLinks

Exhibit 10.1QuickLinks
 -- Click here to rapidly navigate through this document

  

 
 

  Exhibit 10.2    
    

            September 8,
2010 

 VIA HAND DELIVERY  

J.
William Efcavitch 

	Re:
	Separation
Agreement and Release 

Dear
Dr. Efcavitch: 

        This
letter summarizes the terms of your separation from employment with Helicos BioSciences Corporation (the "Company") and the separation agreement and release between you and the
Company (the "Agreement"). The purpose of this Agreement is to establish an amicable arrangement for ending your employment relationship and to release the Company from any claims. With these
understandings and in exchange for the promises by you and the Company as set forth below, you and the Company agree as follows. 

        1.     Employment Status and Final Payments:

        (a)   Your
termination from employment with the Company will be effective as of September 8, 2010 (the "Termination Date"). As of the Termination Date, your salary will
cease, and any entitlement you have or might have under a Company-provided benefit plan, program, contract or practice will terminate, except as required by federal or state law and except with
respect to the Company's group medical and dental plans, which shall be subject to continuation pursuant to Section 1(c) below. To the extent permitted by and under the Company's life insurance
and long term disability policies, you may be eligible to elect to extend your coverage under such policies after the Termination Date at your own cost and expense. 

        (b)   As
of the Termination Date, you will have been paid all wages earned but unpaid and will have been paid for all vacation time accrued but unused as of the Termination
Date. 

        (c)   The
Termination Date shall be the date of the "qualifying event" under the Consolidated Omnibus Budget Reconciliation Act of 1985 ("COBRA") and the Company will present
you with information on COBRA under separate cover. If you timely elect continuation of coverage under COBRA, you may continue participating in the Company's group medical and dental plans in which
you are currently participating ("Group Health Plans") after the Termination Date at your own premium cost subject to the terms of COBRA. 

        2.    Consideration:    In exchange for, and in consideration of, your
full execution of and adherence to this Agreement, and after any applicable revocation period set forth in Section 12 has expired, the Company agrees to provide you with a limited waiver under
Section 2 of the Employee Noncompetition Agreement, dated as of September 7, 2004, between you and the Company (the "Noncompetition Agreement"), whereby pursuant to such limited waiver
the Company shall permit you to accept employment with Affymetrix, Inc. Except with respect to the limited waiver as set forth in the preceding sentence of this Section 2, you hereby
agree and acknowledge that each of the Employee Non-Disclosure and Developments Agreement, dated as of September 7, 2004, between you and the 

 

Company
and the Employee Noncompetition Agreement, shall remain in full force and effect in accordance with their respective terms. 

        3.     Stock Awards/Change in Control Agreement/Housing and Commuting Expenses:

        (a)   As
set forth in the Helicos BioSciences Corporation Stock Option and Incentive Plan and your equity incentive agreements with the Company ("Equity Award Agreements"),
your options to purchase stock in the Company and any restricted stock awards that you hold will cease vesting on the Termination Date. All of your rights and obligations to restricted stock awards
and stock options, including without limitation vesting, exercise and expiration, are governed by the terms and conditions of the Helicos BioSciences Corporation Stock Plan and the Equity Award
Agreements. 

        (b)   You
agree that you shall have no further rights under the Change in Control Agreement between you and the Company dated August 8, 2007 (the "Change in Control
Agreement"), and that as of the Termination Date, the Change in Control Agreement shall be null and void. 

        (c)   You
agree that your current monthly housing allowance and reimbursement of commuting expenses shall terminate as of the Termination Date. 

        4.    Release:    In exchange for the limited
waiver described in Section 2, which are in addition to anything of value to which you are entitled to receive, and other good and valuable consideration, the sufficiency of which is hereby
acknowledged, you and your representatives, agents, estate, heirs, successors and assigns, absolutely and unconditionally hereby release, remise, discharge, indemnify and hold harmless the Company
Releasees (defined to include the Company and/or any of its parents, subsidiaries or affiliates, predecessors, successors or assigns, and its and their respective current and/or former
partners, directors, shareholders/stockholders, officers, employees, attorneys and/or agents, all both individually and in their official capacities), from any and all actions or causes of action,
suits, claims, complaints, contracts, liabilities, agreements, promises, torts, debts, damages, controversies, judgments, rights and demands, whether existing or contingent, known or unknown,
suspected or unsuspected, which arise out of your employment with, change in employment status with, and/or separation of employment from, the Company. This release is intended by you to be all
encompassing and to act as a full and total release of any claims, whether specifically enumerated herein or not, that you may have or have had against the Company Releasees arising from conduct
occurring up to and through the date of this Agreement, including, but not limited to, any claims arising from any federal, state or local law, regulation or constitution dealing with either
employment, employment benefits or employment discrimination such as those laws or regulations concerning discrimination on the basis of race, color, creed, religion, age, sex, sex harassment, sexual
orientation, national origin, ancestry, genetic carrier status, handicap or disability, veteran status, any military service or application for military service, or any other category protected under
federal or state law; any claims under the WARN Act; any contract, whether oral or written, express or implied, including without limitation, any letter offering employment and any equity award
agreement(s); any tort; any claim for equity or other benefits; or any other statutory and/or common law claim. You not only release and discharge the Company Releasees from any and all claims as
stated above that you could make on your own behalf or on behalf of others, but also those claims that might be made by any other person or organization on your behalf, and you specifically waive any
right to recover any damage awards as a member of any class in a case in which any claim(s) against the Company Releasees are made involving any matters. 

        5.     Waiver of Rights and Claims Under the Age Discrimination in Employment Act of 1967:

        Since
you are 40 years of age or older, you are being informed that you have or may have specific rights and/or claims under the Age Discrimination in Employment Act of 1967
(ADEA) and you agree that: 

        (a)   in
consideration for the limited waiver described in Section 2 of this Agreement, which you are not otherwise entitled to receive, you specifically and
voluntarily waive such rights and/or claims 

2

 

under
the ADEA you might have against the Company Releasees to the extent such rights and/or claims arose prior to the date this Agreement was executed; 

        (b)   you
understand that rights or claims under the ADEA which may arise after the date this Agreement is executed are not waived by you; 

        (c)   you
are advised that you have at least 45 days within which to consider the terms of this Agreement and to consult with or seek advice from an attorney of your
choice or any other person of your choosing prior to executing this Agreement, and you acknowledge that you have not been subject to any undue or improper influence interfering with the exercise of
your free will in deciding whether to consult with counsel; 

        (d)   if
you sign this Agreement within less than 45 days of the date of its delivery to you, you acknowledge that by signing this Agreement that such decision was
entirely voluntary and that you had the opportunity to consider this Agreement for the entire 45-day period; 

        (e)   you
have carefully read and fully understand all of the provisions of this Agreement, and you knowingly and voluntarily agree to all of the terms set forth in this
Agreement; 

        (f)    in
entering into this Agreement you are not relying on any representation, promise or inducement made by the Company or its attorneys with the exception of those
promises described in this document; and 

        (g)   you
acknowledge that you have received a Disclosure Memorandum describing certain information required under the ADEA. 

        6.     Period for Review and Consideration of Agreement:

        (a)   You
acknowledge that you were informed and understand that you have forty-five (45) days to review this Agreement and consider its terms before
signing it. 

        (b)   The
45-day review period will not be affected or extended by any revisions, whether material or immaterial, that might be made to this Agreement. 

        7.    Accord and Satisfaction:    The limited waiver set forth herein
shall be complete and unconditional payment, settlement, accord and/or satisfaction with respect to all obligations and liabilities of the Company Releasees to you, including, without limitation, all
claims for back wages, salary, vacation pay, draws, incentive pay, bonuses, stock and stock options, commissions, severance pay, reimbursement of expenses, motor vehicle expenses, moving expenses, any
and all other forms of compensation or benefits, attorney's fees, or other costs or sums. 

        8.    Company Files, Documents and Other Property:    You agree that
on or before the Termination Date you will return to the Company all Company property and materials, including but not limited to, (if applicable) personal computers, laptops, palm pilots and their
equivalent, fax machines, scanners, copiers, cellular phones, Company credit cards and telephone charge cards, manuals, building keys and passes, courtesy parking passes, diskettes, intangible
information stored on diskettes, software programs and data compiled with the use of those programs, software passwords or codes, tangible copies of trade secrets and confidential information, sales
forecasts, names and addresses of Company customers and potential customers, customer lists, customer contacts, sales information, sales forecasts, memoranda, sales brochures, business or marketing
plans, reports, projections, and any and all other information or property previously or currently held or used by you that is or was related to your employment with the Company ("Company Property").
You represent that you have not and will not take by download or otherwise any Company Property. You agree that in the event that you discover any Company Property in your possession, whether in
electronic form or otherwise, after the Termination Date, you will immediately return such materials to the Company. 

3

 

        9.    No Liability or Wrongdoing:    Nothing in this Agreement, nor
any of its terms and provisions, nor any of the negotiations or proceedings connected with it, constitutes, will be construed to constitute, will be offered in evidence as, received in evidence as,
and/or deemed to be evidence of, an admission of liability or wrongdoing by any and/or all of the Company Releasees, and any such liability or wrongdoing is hereby expressly denied by each of the
Company Releasees. 

        10.   Future Conduct:

        (a)    Nondisparagement:    You agree not to make disparaging, critical or otherwise detrimental comments to any
person or entity concerning the Company, its officers, directors or employees; the products, services or programs provided or to be provided by the Company; the business affairs, operation, management
or the financial condition of the Company; or the circumstances surrounding your employment and/or separation of employment from the Company. 

        (b)    Confidentiality of this Agreement:    You agree that you shall not disclose, divulge or publish, directly or
indirectly, any information regarding the substance, terms or existence of this Agreement and/or any discussion or negotiations relating to this Agreement, to any person or organization other than
your immediate family and accountants or attorneys when such disclosure is necessary for the accountants or attorneys to render professional services. Prior to any such disclosure that you may make,
you shall secure from your attorney or accountant their agreement to maintain the confidentiality of such matters. 

        (c)    Disclosures:    Nothing herein shall prohibit or bar you from providing truthful testimony in any legal
proceeding or in communicating with any governmental agency or representative or from making any truthful disclosure required, authorized or permitted under law; provided, however, that in providing
such testimony or making such disclosures or communications, you will use your best efforts to ensure that this Section is complied with to the maximum extent possible. Notwithstanding the foregoing,
nothing in this Agreement shall bar or prohibit you from contacting, seeking assistance from or participating in any proceeding before any federal or state administrative agency to the extent
permitted by applicable federal, state and/or local law. However, you nevertheless will be prohibited to the fullest extent authorized by law from obtaining monetary damages in any agency proceeding
in which you do so participate. 

        (d)    Future Cooperation:    You agree to cooperate reasonably with the Company (including its outside counsel) in
connection with the contemplation, prosecution and defense of all phases of existing, past and future litigation about which the Company believes you may have knowledge or information. You further
agree to make yourself available at mutually convenient times during and outside of regular business hours as reasonably deemed necessary by the Company's counsel. The Company shall not utilize this
Section 10(d) to require you to make yourself available to an extent that would unreasonably interfere with full-time employment responsibilities that you may have. You agree to
appear without the necessity of a subpoena to testify truthfully in any legal proceedings in which the Company calls you as a witness. The Company shall compensate you at the rate of $200.00 per hour
for services provided by you pursuant to this Section 10(d); provided that the Company shall not be obligated to compensate you for any time that you could be compelled to expend if you were
subpoenaed by the Company. The Company shall also reimburse you for any pre-approved reasonable business travel expenses that you incur on the Company's behalf as a result of your
litigation cooperation services, after receipt of appropriate documentation consistent with the Company's business expense reimbursement policy. 

        11.   Representations and Governing Law:

        (a)   This
Agreement sets forth the complete and sole agreement between the parties and supersedes any and all other agreements or understandings, whether oral or written.
This Agreement 

4

 

may
not be changed, amended, modified, altered or rescinded except upon the express written consent of the Company and you. 

        (b)   If
any provision of this Agreement, or part thereof, is held invalid, void or voidable as against public policy or otherwise, the invalidity shall not affect other
provisions, or parts thereof, which may be given effect without the invalid provision or part. To this extent, the provisions and parts thereof of this Agreement are declared to be severable. Any
waiver of any provision of this Agreement shall not constitute a waiver of any other provision of this Agreement unless expressly so indicated otherwise. The language of all parts of this Agreement
shall in all cases be construed according to its fair meaning and not strictly for or against either of the parties. 

        (c)   This
Agreement and any claims arising out of this Agreement (or any other claims arising out of the relationship between the parties) shall be governed by and construed
in accordance with the laws of the Commonwealth of Massachusetts and shall in all respects be interpreted, enforced and governed under the internal and domestic laws of Massachusetts, without giving
effect to the principles of conflicts of laws of such state. Any claims or legal actions by one party against the other shall be commenced and maintained in a state or federal court located in
Massachusetts, and you hereby submit to the jurisdiction and venue of any such court. 

        (d)   You
represent that you have not been subject to any retaliation or any other form of adverse action by the Company Releasees for any action taken by you as an employee
of the Company or resulting from your exercise of or attempt to exercise any statutory rights recognized under federal, state or local law. 

        (e)   You
may not assign any of your rights or delegate any of your duties under this Agreement. The rights and benefits of this Agreement shall inure to the benefit of the
Company's successors and assigns. 

        12.    Effective Date:    After signing this letter, you may revoke
this Agreement for a period of seven (7) days following said execution. The Agreement shall not become effective or enforceable and no payments will be made pursuant to this Agreement until
this revocation period has expired ("Effective Date"). 

5

 

        If
this letter correctly states the agreement and understanding we have reached, please indicate your acceptance by countersigning the enclosed copy and returning it to me. 

 

 

					
	

 	
 	
Very truly yours,
 Helicos BioSciences Corporation
	

 	
 	
By:	
 	
/s/ Ronald A. Lowy

 Company Representative

 

         I
REPRESENT THAT I HAVE READ THE FOREGOING AGREEMENT, THAT I FULLY UNDERSTAND THE TERMS AND CONDITIONS OF SUCH AGREEMENT AND THAT I AM KNOWINGLY AND VOLUNTARILY EXECUTING THE SAME. IN
ENTERING INTO THIS AGREEMENT, I DO NOT RELY ON ANY REPRESENTATION, PROMISE OR INDUCEMENT MADE BY THE COMPANY OR ITS REPRESENTATIVES WITH THE EXCEPTION OF THE CONSIDERATION DESCRIBED IN THIS DOCUMENT. 

 

 

			
	Accepted and Agreed to:	 	 
	
 /s/ J. William Efcavitch

  J. William Efcavitch	
 	

 
	
 Date: September 8, 2010

	
 	

 

 

 6

QuickLinks

Exhibit 10.2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}]]